APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pimozide

Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.

Selected research

Market Structure

Global Pimozide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025186 pages

Choose your research edition.

Industry ResearchPimozide Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Pimozide Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Pimozide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pimozide Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Pimozide Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.

Global Pimozide key players include Teva, Par Pharmaceutical, Johnson & Johnson, etc. Global top three manufacturers hold a share about 80%.

North America is the largest market, with a share about 40%, followed by Europe and South America, both have a share about 45 percent.

Read the full market overview

In terms of product, 2Mg is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospitals, followed by Drugstores, etc.

This report provides an overview of the global Pimozide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pimozide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pimozide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pimozide market size, projected growth trends, production technologies, key applications, and end-use industries.

Pimozide Segment by Company

Teva

Par Pharmaceutical

Johnson & Johnson

Eumedica

Pharmascience

Domina Pharmaceuticals

Aa Pharma

Pimozide Segment by Type

1Mg

2Mg

4Mg

Pimozide Segment by Application

Hospitals

Drugstores

Others

Pimozide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pimozide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pimozide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pimozide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pimozide market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pimozide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pimozide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pimozide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pimozide Industry Trends Table 2. Pimozide Industry Drivers Table 3. Pimozide Industry Opportunities and Challenges Table 4. Pimozide Industry Restraints Table 5. Global Pimozide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pimozide Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pimozide Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Pimozide Sales Market Share by Manufacturers Table 9. Global Pimozide Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Pimozide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pimozide Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pimozide Manufacturers, Product Type & Application Table 13. Global Pimozide Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pimozide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 1Mg Table 17. Major Manufacturers of 2Mg Table 18. Major Manufacturers of 4Mg Table 19. Global Pimozide Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Pimozide Sales by Type (2021-2026) & (K Units) Table 21. Global Pimozide Sales by Type (2027-2032) & (K Units) Table 22. Global Pimozide Sales Market Share by Type (2021-2026) Table 23. Global Pimozide Sales Market Share by Type (2027-2032) Table 24. Global Pimozide Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Pimozide Revenue by Type (2021-2026) & (K Units) Table 26. Global Pimozide Revenue by Type (2027-2032) & (K Units) Table 27. Global Pimozide Revenue Market Share by Type (2021-2026) Table 28. Global Pimozide Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospitals Table 30. Major Manufacturers of Drugstores Table 31. Major Manufacturers of Others Table 32. Global Pimozide Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Pimozide Sales by Application (2021-2026) & (K Units) Table 34. Global Pimozide Sales by Application (2027-2032) & (K Units) Table 35. Global Pimozide Sales Market Share by Application (2021-2026) Table 36. Global Pimozide Sales Market Share by Application (2027-2032) Table 37. Global Pimozide Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Pimozide Revenue by Application (2021-2026) & (K Units) Table 39. Global Pimozide Revenue by Application (2027-2032) & (K Units) Table 40. Global Pimozide Revenue Market Share by Application (2021-2026) Table 41. Global Pimozide Revenue Market Share by Application (2027-2032) Table 42. Global Pimozide Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Pimozide Sales by Region (2021-2026) & (K Units) Table 44. Global Pimozide Sales Market Share by Region (2021-2026) Table 45. Global Pimozide Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Pimozide Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Pimozide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Pimozide Sales by Country (2021-2026) & (K Units) Table 49. North America Pimozide Sales by Country (2027-2032) & (K Units) Table 50. Europe Pimozide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Pimozide Sales by Country (2021-2026) & (K Units) Table 52. Europe Pimozide Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Pimozide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Pimozide Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Pimozide Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Pimozide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Pimozide Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Pimozide Sales by Country (2027-2032) & (K Units) Table 59. Global Pimozide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Pimozide Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Pimozide Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Pimozide Revenue Market Share by Region (2021-2026) Table 63. Global Pimozide Revenue Market Share by Region (2027-2032) Table 64. Teva Company Information Table 65. Teva Business Overview Table 66. Teva Pimozide Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Teva Pimozide Product Portfolio Table 68. Teva Recent Development Table 69. Par Pharmaceutical Company Information Table 70. Par Pharmaceutical Business Overview Table 71. Par Pharmaceutical Pimozide Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Par Pharmaceutical Pimozide Product Portfolio Table 73. Par Pharmaceutical Recent Development Table 74. Johnson & Johnson Company Information Table 75. Johnson & Johnson Business Overview Table 76. Johnson & Johnson Pimozide Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Johnson & Johnson Pimozide Product Portfolio Table 78. Johnson & Johnson Recent Development Table 79. Eumedica Company Information Table 80. Eumedica Business Overview Table 81. Eumedica Pimozide Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Eumedica Pimozide Product Portfolio Table 83. Eumedica Recent Development Table 84. Pharmascience Company Information Table 85. Pharmascience Business Overview Table 86. Pharmascience Pimozide Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Pharmascience Pimozide Product Portfolio Table 88. Pharmascience Recent Development Table 89. Domina Pharmaceuticals Company Information Table 90. Domina Pharmaceuticals Business Overview Table 91. Domina Pharmaceuticals Pimozide Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Domina Pharmaceuticals Pimozide Product Portfolio Table 93. Domina Pharmaceuticals Recent Development Table 94. Aa Pharma Company Information Table 95. Aa Pharma Business Overview Table 96. Aa Pharma Pimozide Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Aa Pharma Pimozide Product Portfolio Table 98. Aa Pharma Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Pimozide Distributors List Table 102. Pimozide Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Pimozide Product Image Figure 2. Global Pimozide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pimozide Market Size (2021-2032) & (US$ Million) Figure 4. Global Pimozide Sales (2021-2032) & (K Units) Figure 5. Global Pimozide Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pimozide Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 1Mg Image Figure 9. 2Mg Image Figure 10. 4Mg Image Figure 11. Global Pimozide Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Pimozide Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Pimozide Sales Market Share by Type (2021-2032) Figure 14. Global Pimozide Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Pimozide Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Pimozide Revenue Market Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Drugstores Image Figure 19. Others Image Figure 20. Global Pimozide Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Pimozide Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Pimozide Sales Market Share by Application (2021-2032) Figure 23. Global Pimozide Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Pimozide Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Pimozide Revenue Market Share by Application (2021-2032) Figure 26. North America Pimozide Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Pimozide Sales Market Share by Country (2021-2032) Figure 28. U.S. Pimozide Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Pimozide Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Pimozide Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Pimozide Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Pimozide Sales Market Share by Country (2021-2032) Figure 33. Germany Pimozide Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Pimozide Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Pimozide Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Pimozide Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Pimozide Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Pimozide Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Pimozide Sales Market Share by Country (2021-2032) Figure 40. China Pimozide Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Pimozide Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Pimozide Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Pimozide Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Pimozide Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Pimozide Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Pimozide Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Pimozide Sales Market Share by Country (2021-2032) Figure 48. Brazil Pimozide Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Pimozide Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Pimozide Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Pimozide Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Pimozide Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Pimozide Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Pimozide Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Pimozide Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Pimozide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Pimozide Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Pimozide Revenue (2021-2032) & (US$ Million) Figure 59. North America Pimozide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Pimozide Revenue (2021-2032) & (US$ Million) Figure 61. Europe Pimozide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Pimozide Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Pimozide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Pimozide Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Pimozide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Pimozide Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Pimozide Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 1Mg
  • 2Mg
  • 4Mg
Applications
  • Hospitals
  • Drugstores
  • Others
Companies covered
  • Teva
  • Par Pharmaceutical
  • Johnson & Johnson
  • Eumedica
  • Pharmascience
  • Domina Pharmaceuticals
  • Aa Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pimozide Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pimozide Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pimozide Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pimozide Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pimozide Market Dynamics
  1. 2.1 Pimozide Industry Trends
  2. 2.2 Pimozide Industry Drivers
  3. 2.3 Pimozide Industry Opportunities and Challenges
  4. 2.4 Pimozide Industry Restraints
3 Pimozide Market by Manufacturers
  1. 3.1 Global Pimozide Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pimozide Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pimozide Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pimozide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pimozide Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pimozide Manufacturers, Product Type & Application
  7. 3.7 Global Pimozide Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pimozide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pimozide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pimozide Tier 1, Tier 2, and Tier 3
4 Pimozide Market by Type
  1. 4.1 Pimozide Type Introduction
  2. 4.1.1 1Mg
  3. 4.1.2 2Mg
  4. 4.1.3 4Mg
  5. 4.2 Global Pimozide Sales by Type
  6. 4.2.1 Global Pimozide Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Pimozide Sales by Type (2021-2032)
  8. 4.2.3 Global Pimozide Sales Market Share by Type (2021-2032)
  9. 4.3 Global Pimozide Revenue by Type
  10. 4.3.1 Global Pimozide Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Pimozide Revenue by Type (2021-2032)
  12. 4.3.3 Global Pimozide Revenue Market Share by Type (2021-2032)
5 Pimozide Market by Application
  1. 5.1 Pimozide Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Drugstores
  4. 5.1.3 Others
  5. 5.2 Global Pimozide Sales by Application
  6. 5.2.1 Global Pimozide Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pimozide Sales by Application (2021-2032)
  8. 5.2.3 Global Pimozide Sales Market Share by Application (2021-2032)
  9. 5.3 Global Pimozide Revenue by Application
  10. 5.3.1 Global Pimozide Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pimozide Revenue by Application (2021-2032)
  12. 5.3.3 Global Pimozide Revenue Market Share by Application (2021-2032)
6 Global Pimozide Sales by Region
  1. 6.1 Global Pimozide Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pimozide Sales by Region (2021-2032)
  3. 6.2.1 Global Pimozide Sales by Region (2021-2026)
  4. 6.2.2 Global Pimozide Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pimozide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pimozide Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pimozide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pimozide Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pimozide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pimozide Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pimozide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pimozide Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pimozide Revenue by Region
  1. 7.1 Global Pimozide Revenue by Region
  2. 7.1.1 Global Pimozide Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pimozide Revenue by Region (2021-2026)
  4. 7.1.3 Global Pimozide Revenue by Region (2027-2032)
  5. 7.1.4 Global Pimozide Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pimozide Revenue (2021-2032)
  8. 7.2.2 North America Pimozide Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pimozide Revenue (2021-2032)
  11. 7.3.2 Europe Pimozide Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pimozide Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pimozide Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pimozide Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pimozide Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Pimozide Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pimozide Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Par Pharmaceutical
  8. 8.2.1 Par Pharmaceutical Company Information
  9. 8.2.2 Par Pharmaceutical Business Overview
  10. 8.2.3 Par Pharmaceutical Pimozide Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Par Pharmaceutical Pimozide Product Portfolio
  12. 8.2.5 Par Pharmaceutical Recent Developments
  13. 8.3 Johnson & Johnson
  14. 8.3.1 Johnson & Johnson Company Information
  15. 8.3.2 Johnson & Johnson Business Overview
  16. 8.3.3 Johnson & Johnson Pimozide Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Johnson & Johnson Pimozide Product Portfolio
  18. 8.3.5 Johnson & Johnson Recent Developments
  19. 8.4 Eumedica
  20. 8.4.1 Eumedica Company Information
  21. 8.4.2 Eumedica Business Overview
  22. 8.4.3 Eumedica Pimozide Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Eumedica Pimozide Product Portfolio
  24. 8.4.5 Eumedica Recent Developments
  25. 8.5 Pharmascience
  26. 8.5.1 Pharmascience Company Information
  27. 8.5.2 Pharmascience Business Overview
  28. 8.5.3 Pharmascience Pimozide Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pharmascience Pimozide Product Portfolio
  30. 8.5.5 Pharmascience Recent Developments
  31. 8.6 Domina Pharmaceuticals
  32. 8.6.1 Domina Pharmaceuticals Company Information
  33. 8.6.2 Domina Pharmaceuticals Business Overview
  34. 8.6.3 Domina Pharmaceuticals Pimozide Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Domina Pharmaceuticals Pimozide Product Portfolio
  36. 8.6.5 Domina Pharmaceuticals Recent Developments
  37. 8.7 Aa Pharma
  38. 8.7.1 Aa Pharma Company Information
  39. 8.7.2 Aa Pharma Business Overview
  40. 8.7.3 Aa Pharma Pimozide Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Aa Pharma Pimozide Product Portfolio
  42. 8.7.5 Aa Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pimozide Value Chain Analysis
  2. 9.1.1 Pimozide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pimozide Production Mode & Process
  6. 9.2 Pimozide Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pimozide Distributors
  9. 9.2.3 Pimozide Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst